News Detail
New Delhi, 6 Nov 2024: Roche, a Swiss multinational healthcare company, is seeking a permanent injunction against Natco Pharma to prevent the introduction of a generic version of Risdiplam, a Spinal Muscular Atrophy (SMA) drug, citing patent infringement.
H......
View Details
Source : The Telegraph India
Roche
spinal muscular atrophy
Natco Pharma
patent
generic drug
Delhi High Court
Related News
- Dehradun police busted drug manufacturing Unit operated under the guise of 'Green Herbal Factory' in Sahaspur area (06-12-2024)
- Ballari maternal deaths: Ready to resign if I'm at fault, says Karnataka HM (06-12-2024)
- FDA Approves New Drug for Lung and Pancreatic Cancers (06-12-2024)
- Surat police nab 13 bogus doctors in fake degree scam (06-12-2024)
- Maternal death toll in Ballari hospital touches five after one more woman dies (06-12-2024)
- Two sacks of medicines recovered from a government flat in Saharanpur (06-12-2024)
- Action taken against 116 Pharma companies in Himachal found not meeting standards (05-12-2024)
- Govt allocates Rs 4534.28 Crores for promotion of AYUSH (05-12-2024)
- FDA finalizes AI-enabled medical device life cycle plan guidance (05-12-2024)
- Tumakuru police seize 1,700 tapentadol tablets sold over the counter (05-12-2024)